GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (A2S924)

Analyse AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (A2S924) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A2S924
Type
protein
Length
306 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x18762eA40ffc26417675C60f0F519A7FC779932d
Molecule
Tryptophan 2,3-dioxygenase
UniProt
A2S924
Pockets
2 · best druggability 0.78

Structure

1 distinct chain · 60% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATryptophan 2,3-dioxygenaseprotein30660% helix, 0% strandA2S924

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15570.780.8454empty
2550.380.8015empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.